408 related articles for article (PubMed ID: 11649694)
1. The regulation of recombinant DNA research: the alternative of local control.
Rosenblatt DP
Boston Coll Environ Aff Law Rev; 1982; 10(1):37-78. PubMed ID: 11649694
[No Abstract] [Full Text] [Related]
2. Recombinant DNA: legal responses to a new biohazard.
Balmer TA
Environ Law; 1977; 7(2):293-313. PubMed ID: 11661448
[No Abstract] [Full Text] [Related]
3. Recombinant DNA: a case study in regulation of scientific research.
Chalfant JC; Hartmann ME; Blakeboro A
Ecol Law Q; 1979; 8(1):55-129. PubMed ID: 11665069
[No Abstract] [Full Text] [Related]
4. Recombinant DNA and technology assessment.
Georgetown Law J; 1977; 11(4):785-878. PubMed ID: 11664859
[No Abstract] [Full Text] [Related]
5. Introduction to recombinant DNA research, development and evolution of the NIH guidelines, and proposed legislation.
Talbot B
Univ Toledo Law Rev; 1981; 12(4):804-14. PubMed ID: 11649587
[No Abstract] [Full Text] [Related]
6. An historical development of patenting microorganisms and genetically engineered animals in the USA and Europe.
McTaggart RJ
Eur J Genet Soc; 1996; 2(1):2-14. PubMed ID: 11658254
[No Abstract] [Full Text] [Related]
7. Reasonableness versus rationality in the construction and justification of science policy decisions: the case of the Cambridge Experimentation Review Board.
Waddell C
Sci Technol Human Values; 1989; 14(1):7-25. PubMed ID: 11650830
[No Abstract] [Full Text] [Related]
8. Recombinant DNA and the regulation of biotechnology: reflections on the Asilomar Conference, ten years after.
Barkstrom JE
Akron Law Rev; 1985; 19(1):81-126. PubMed ID: 11650740
[No Abstract] [Full Text] [Related]
9. Patenting of life forms.
Pautler G
Trial; 1982 Apr; 18(4):47-50, 76. PubMed ID: 11649513
[No Abstract] [Full Text] [Related]
10. Molecular politics in a global economy.
Wright S
Politics Life Sci; 1996 Sep; 15(2):249-63. PubMed ID: 11654797
[No Abstract] [Full Text] [Related]
11. Institutional biosafety committees and the inadequacies of risk regulation.
Bereano PL
Sci Technol Human Values; 1984; 9(4):16-34. PubMed ID: 11649608
[No Abstract] [Full Text] [Related]
12. An unprecedented debate.
Norman C
Nature; 1977 Feb; 265(5595):575-7. PubMed ID: 11643373
[No Abstract] [Full Text] [Related]
13. Regulating biotechnology.
McGarity TO
Issues Sci Technol; 1985; 1(3):40-56. PubMed ID: 11649701
[No Abstract] [Full Text] [Related]
14. Recombinant DNA research: proposed actions under the guidelines; notice.
U.S. National Institutes of Health
Fed Regist; 1997 Feb; 62(31):7108-23. PubMed ID: 11654870
[No Abstract] [Full Text] [Related]
15. Coordinated framework for regulation of biotechnology; announcement of policy; notice for public comment.
U.S. Office of Science and Technology Policy
Fed Regist; 1986 Jun; 51(123):23302-50. PubMed ID: 11655807
[No Abstract] [Full Text] [Related]
16. The politics of deoxyribonucleic acid.
Budrys A
New Repub; 1977 Apr; 176(16):18-21. PubMed ID: 11662375
[No Abstract] [Full Text] [Related]
17. Coordinated framework for regulation of biotechnology; establishment of the Biotechnology Science Coordinating Committee; notice.
U.S. Office of Science and Technology Policy
Fed Regist; 1985 Nov; 50(220):47174-95. PubMed ID: 11655733
[No Abstract] [Full Text] [Related]
18. From Asilomar to industrial biotechnology: risks, reductionism and regulation.
Krimsky S
Sci Cult (Lond); 2005 Dec; 14(4):309-23. PubMed ID: 16619467
[No Abstract] [Full Text] [Related]
19. Regulation of genetic engineering: less concern about Frankensteins but time for action on commercial production.
Karny GM
Univ Toledo Law Rev; 1981; 12(4):815-68. PubMed ID: 11649588
[No Abstract] [Full Text] [Related]
20. Recombinant DNA research; actions under guidelines; notice.
U.S. National Institutes of Health
Fed Regist; 1984 Apr; 49(81):17844-8. PubMed ID: 11655581
[No Abstract] [Full Text] [Related]
[Next] [New Search]
